Quince Therapeutics Inc
QNCX
NASDAQ
Biotechnology
$34.04
USD
+1.63 (+5.03%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $33.61M
Volume 25.9K
Price Target
$80.00 – $80.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $80.00 and a min estimate of $80.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$80.00
Implied Upside
+135.0%
Analyst Covering
2
Consensus
Buy
Signal Quality
Consensus Freshness
100%
Most ratings are recent - from the last 3 months
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Joseph Schwartz | Leerink Partners | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Olivia Brayer Saunders | Cantor Fitzgerald | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
